Inspiration We were inspired by the urgent, ongoing challenges Thalassemia patients face in receiving timely blood transfusions. Stories from affected families and grassroots organizations like Blood Warriors motivated us to find a smarter, scalable way to connect patients and donors, alleviate the constant search stress, and ultimately save more lives.
What it does Our platform uses AI to match Thalassemia patients with available blood donors in real time, predicts future blood requirements, and automates outreach to potential donors. It integrates with existing blood bank systems and includes educational tools to raise awareness within the community.
How we built it We researched pain points through interviews with patients and NGOs, then designed a web/mobile app using Azure’s AI services. We developed a predictive model for blood needs, real-time donor matching algorithms, and user-centered interfaces. Security and privacy were prioritized using best-practice protocols and encrypted data handling.
Challenges we ran into We faced hurdles integrating with government blood bank APIs and ensuring data privacy for users. Predicting donor availability proved complex, needing ongoing data refinements. Designing for inclusivity, supporting multiple languages, and making technology accessible for diverse users required multiple iterations.
Accomplishments that we're proud of We created a working prototype that accurately matches patients with donors and predicts blood needs. We made the platform intuitive and accessible, with instant notifications that improve response rates. Our educational modules are multilingual, increasing engagement and awareness.
What we learned We learned how crucial user empathy is when developing healthcare solutions, especially for vulnerable groups. Continuous feedback from real users shaped our design. We also deepened our technical skills in AI, real-time data integration, and secure healthcare app development.
What's next for ThalassoConnect We plan to integrate more regional blood banks, expand to cover additional rare diseases, and continue improving prediction accuracy. We also aim to partner with NGOs and hospitals for pilot deployments, and enhance our educational offerings for wider public impact.
Log in or sign up for Devpost to join the conversation.